dialec medical services

Citra-Lock™ 4%

the safe & effective way to lock every central catheter

Citra-Lock™ 4% is recommended in the European Renal Best Practice Guidelines (ERBP) and the American Society of Diagnostic and Interventional Nephrology (ASDIN).

Citra locks have been extensively studied.

Citra-Lock™ 4% offers the best benefit/risk ratio.

Weijmer JC, Superior Antimicrobial Activity of Trisodium Citrate over Heparin for Cahteter Locking. Nephrol Dial Transplant 17:2189-2195, 2002

Citra-Lock™ is effective in maintaining catheter patency.

Trisodium Citrate 4% (TSC) works as an anti-coagulant and decreases the incidence of infection.

Clinical advantage of Citra-Lock™ 4% (compared to heparine):

• safe
• avoids heparin-associated bleeding
• improves reliability of INR assyas (prothrombin time – time/international normalised ratio)
• safe for heparin induced thrombocytopenia (HIT patients)
• no side effects
• reduction of tPA use
• better outcomes over catheter exchange
• reduces biofilm
• reduction of hospitalisation
• cost efficient

Increase Safety & Simplified handling

The Citra-Lock™ vial features a drip free Luer-Slip/Luer-Lock connector:

• preventing microbial contamination
• protecting against needle stick injuries
• reducing handling steps
• promoting intuitive handing

Download References  / Publications Citra-Lock™

Citra-Lock™ 4% 5ml vial

Boxes contain 20 x 5ml vials

Art. code: 24060201